NCT03857893 - New Non-Hormonal Treatment by Radiofrequency for Vulvo-Vaginal Atrophy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

December 8, 2021

Study Completion Date

December 8, 2021

Conditions

Vulvo-vaginal AtrophyGenitourinary Syndrome of Menopause

Interventions

DEVICE

Dynamic Quadripolar Radio-Frequency treatment

"Novel low-energy Dynamic Quadripolar Radio-frequency thermal treatment through Eva™ Device. Eva™ Device combines both advanced VDR™ technology (Vaginal Dynamic Radiofrequency) and RSS™ (Radiofrequency Safely System) technology."

DRUG

pH-Cream

1g of Cetomacrogol cream (pH-cream) to self-administered with a vaginal applicator for 12 weeks (one dose every three days)

Trial Locations (5)

Unknown

CHU Brugmann, Brussels

CHU Saint-Pierre, Brussels

Hôpital Erasme, Brussels

Hôpitaux Iris Sud, Brussels

Jules Institute Bordet, Brussels